GB1486869A - Pyridoquinolines - Google Patents

Pyridoquinolines

Info

Publication number
GB1486869A
GB1486869A GB2129075A GB2129075A GB1486869A GB 1486869 A GB1486869 A GB 1486869A GB 2129075 A GB2129075 A GB 2129075A GB 2129075 A GB2129075 A GB 2129075A GB 1486869 A GB1486869 A GB 1486869A
Authority
GB
United Kingdom
Prior art keywords
triazolo
alkoxy
alkyl
dihydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2129075A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB2129075A priority Critical patent/GB1486869A/en
Priority to DE19762621828 priority patent/DE2621828A1/en
Priority to FR7614971A priority patent/FR2311544A1/en
Priority to JP51057746A priority patent/JPS52297A/en
Publication of GB1486869A publication Critical patent/GB1486869A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1486869 Compositions containing pyridoquinolines IMPERIAL CHEMICAL INDUSTRIES Ltd 21 April 1976 [19 May 1975] 21290/75 Heading A5B [Also in Division C2] Theropeutic compositions comprise compounds of formulae wherein R<SP>1</SP> is H or the same as R<SP>2</SP>; R<SP>2</SP> is CH 2 R, CHMeR or CHEtR, R being CN, C 2-4 alkanoyl, benzoyl, C 2-6 alkanolyloxy, (C 1-5 - alkoxy) carbonyl, Ph-(C 1-3 alkoxy) carbonyl or C 3-7 -(dialkylcarbamoyl); and benzene ring B may be substituted by C 1-6 alkyl, C 1-6 alkoxy or/and halogen. They may be administered orally or intravenously to treat intrinsic (non- allergic) asthma, or a disease or syndrome initiated by antigen-antibody reaction e.g. allergic asthma, hay fever, urticaria or an autoimmune disease. They may contain additionally beta-adrenergic stimulants (e.g. isoprenaline, adrenaline, orciprenaline or isoethacine), prostaglandins (e.g. E, or E 2 ) having bronchodilatory activity, or phosphodiesterase inhibitors (e.g. 3-acetamido-6-methyl-8-n-propyl-s-triazolo [4, 3-a] pyrazine, 2-amino-4, 6- di-C 1-4 -alkyl-5-oxo-4, 5-dihydro-s-triazolo [1, 5-a] pyrmidines, theophylline and related 3, 5-di-C 1-4 -alkylxanthines; and 6, 8-di-C 1-4 alkyl -5, 6-dihydro-5-oxo-s-triazolo [4, 3-c] pyrimidines).
GB2129075A 1975-05-19 1975-05-19 Pyridoquinolines Expired GB1486869A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB2129075A GB1486869A (en) 1975-05-19 1975-05-19 Pyridoquinolines
DE19762621828 DE2621828A1 (en) 1975-05-19 1976-05-17 PYRIDOCHINOLINS, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
FR7614971A FR2311544A1 (en) 1975-05-19 1976-05-18 NEW PYRIDOQUINOLEINS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
JP51057746A JPS52297A (en) 1975-05-19 1976-05-19 Production of pyridquinline derivative and pharmaceutical composition containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2129075A GB1486869A (en) 1975-05-19 1975-05-19 Pyridoquinolines

Publications (1)

Publication Number Publication Date
GB1486869A true GB1486869A (en) 1977-09-28

Family

ID=10160384

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2129075A Expired GB1486869A (en) 1975-05-19 1975-05-19 Pyridoquinolines

Country Status (4)

Country Link
JP (1) JPS52297A (en)
DE (1) DE2621828A1 (en)
FR (1) FR2311544A1 (en)
GB (1) GB1486869A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54115524A (en) * 1978-02-28 1979-09-08 Kazuo Ueishi Compound ball wave weakening method
JPS6012428A (en) * 1983-07-04 1985-01-22 Canon Inc Sheet feeder
US4555520A (en) * 1984-08-20 1985-11-26 E. R. Squibb & Sons, Inc. 2-Pyridylcarboxamides which inhibit arachidonic acid release

Also Published As

Publication number Publication date
JPS52297A (en) 1977-01-05
DE2621828A1 (en) 1976-12-02
FR2311544A1 (en) 1976-12-17

Similar Documents

Publication Publication Date Title
AU2828589A (en) Method of inhibiting the activity of leukocyte derived cytokines
ATE195738T1 (en) PYRAZOLOPYRIMIDINES AS CRF ANTAGONISTS
ES391026A1 (en) Benzonaphthyridine derivatives
IE44105L (en) Imidazolyl-alkyl sulphides
GB1486869A (en) Pyridoquinolines
GB1392475A (en) Hydrazino-pyrimido-pyridazine derivative
GB1487535A (en) Pyridoquinolines
GB1477302A (en) Triazolo-isoindole and triazolo-isoquinoline derivatives and their manufacture and uses
SE7703395L (en) NICOTINOYLAMINOTRIAZINDERIVAT
GB2010833A (en) Homoeburnamine preparation
GB1366319A (en) Sa 8-amino-theohylline derivatives process for their preparation and therapeutic compositon containing same
FR2405953A1 (en) DERIVATIVES OF METHOXY-7A-THIOMETHYLHETEROCYCLIQUE-3-CEPHALOSPORIN REPRESENTING ANTI-BACTERIAL ACTIVITY
ES557223A1 (en) A METHOD FOR PREPARING 1-ARIL-DELTA 2-1,2,4-TRIAZOLIL-5-ONAS (Machine-translation by Google Translate, not legally binding)
GB1311005A (en) Dibenzocycloheptene derivatives
JPS52102281A (en) Tetrahydroisoquinoline derivatives
JPS6476063A (en) Electrophotographic sensitive body
JPS51136695A (en) Process for preparing new pyrimido(4,5-d)pyrimidine derivatives
GB1285333A (en) Oxadiazolophthalazines
SU793143A1 (en) Photothermoplastic media
GB1415039A (en) 6-aminouracil derivatives
ES436233A2 (en) Derivatives of substituted tetrahydro-m-oxazines
SU1336469A1 (en) METHOD OF OBTAINING C-C OLEFINS
GB1377353A (en) N-phenyl amidines
GB1370898A (en) Preparation of 2-styrylbenzopyrans
SU782287A1 (en) METHOD FOR PRODUCING CYCLOPROPANE HYDROCARBONS

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed